162 related articles for article (PubMed ID: 37933831)
1. Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta-analysis.
Melin JM; Forslund M; Alesi SJ; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena AS; Witchel SF; Mousa A; Teede HJ
Clin Endocrinol (Oxf); 2024 Feb; 100(2):149-163. PubMed ID: 37933831
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Thiazolidinediones in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Adv Ther; 2024 Jun; 41(6):2168-2195. PubMed ID: 38683294
[TBL] [Abstract][Full Text] [Related]
3. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Morley LC; Tang T; Yasmin E; Norman RJ; Balen AH
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003053. PubMed ID: 29183107
[TBL] [Abstract][Full Text] [Related]
4. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
Lord JM; Flight IH; Norman RJ
Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
[TBL] [Abstract][Full Text] [Related]
5. Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Clin Endocrinol (Oxf); 2022 Jun; 96(6):758-780. PubMed ID: 34918367
[TBL] [Abstract][Full Text] [Related]
6. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2010 Jan; (1):CD003053. PubMed ID: 20091537
[TBL] [Abstract][Full Text] [Related]
7. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2012 May; (5):CD003053. PubMed ID: 22592687
[TBL] [Abstract][Full Text] [Related]
8. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
9. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2009 Oct; (4):CD003053. PubMed ID: 19821299
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
Shyangdan D; Clar C; Ghouri N; Henderson R; Gurung T; Preiss D; Sattar N; Fraser A; Waugh N
Health Technol Assess; 2011 Nov; 15(38):1-110. PubMed ID: 22059955
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H; Xing C; Zhang J; He B
Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome.
Du Q; Wang YJ; Yang S; Wu B; Han P; Zhao YY
Curr Med Res Opin; 2012 May; 28(5):723-30. PubMed ID: 22462531
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and other effects of pioglitazone as an add-on therapy to metformin in the treatment of polycystic ovary syndrome (PCOS).
Valsamakis G; Lois K; Kumar S; Mastorakos G
Hormones (Athens); 2013; 12(3):363-78. PubMed ID: 24121378
[TBL] [Abstract][Full Text] [Related]
14. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
[TBL] [Abstract][Full Text] [Related]
15. Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome.
Liao L; Tian YJ; Zhao JJ; Xin Y; Xing HY; Dong JJ
Chin Med J (Engl); 2011 Mar; 124(5):714-8. PubMed ID: 21518564
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones for treatment of polycystic ovary syndrome.
Stout DL; Fugate SE
Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
18. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
[TBL] [Abstract][Full Text] [Related]
19. Insulin-sensitisers in the treatment of polycystic ovary syndrome.
Teede HJ; Meyer C; Norman RJ
Expert Opin Pharmacother; 2005 Nov; 6(14):2419-27. PubMed ID: 16259573
[TBL] [Abstract][Full Text] [Related]
20. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
Mitkov M; Pehlivanov B; Terzieva D
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):93-8. PubMed ID: 16360262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
